Noble Capital Markets has invested in 2 companies and its latest investment was Onconova Therapeutics on Sep 27, 2021
FOLLOW STATUS
COMPANY
DESCRIPTION
AMOUNT
INVESTMENT DATE
ROUND
EXIT DATE
Onconova is a Pennsylvania-based biopharmaceutical company that develops and commercializes novel products for the treatment of cancer.
$21M
Sep 27, 2021
-
OST is an-England based clinical stage biopharmaceutical company that research and develops products for the treatment of osteosarcoma and other solid tumors.
$6M
Apr 19, 2021
-
Frequently Asked Questions about Noble Capital Markets
What is Noble Capital Markets investing in?
Noble Capital Markets has invested in 2 companies including Onconova Therapeutics and OS Therapies
What company did Noble Capital Markets invest in?
Noble Capital Markets invested in a total 2 companies including Onconova Therapeutics and OS Therapies
What are the top 2 investments by Noble Capital Markets?
The top companies in which Noble Capital Markets invested are Onconova Therapeutics and OS Therapies